Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.39 USD | -10.97% | -1.24% | 0.00% |
Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- Official Publications